Novo Nordisk, Sanofi Cap Feud Over Insulin Pen
Judge Mary Cooper of the U.S. District Court for the District of New Jersey signed off on a joint stipulation of dismissal with prejudice Monday.
Attorneys for Sanofi-Aventis and Novo could not immediately be reached to comment on the apparent settlement, which puts to rest more than two years of litigation.
Denmark-based drugmaker Novo originally sued Sanofi-Aventis in...
To view the full article, register now.